Suzhou Basecare Medical Corp. Ltd. Class H (HK:2170) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Suzhou Basecare Medical Corp. Ltd. has received approval from China’s National Medical Products Administration to renew the registration of its innovative PGT-A kit until 2030. This renewal underscores the kit’s proven clinical efficacy, having demonstrated 100% concordance in over 100,000 clinical samples. The PGT-A kit is a significant advancement in the field of genetic testing in China, providing accurate analysis for embryo implantation decisions.
For further insights into HK:2170 stock, check out TipRanks’ Stock Analysis page.